149 related articles for article (PubMed ID: 14573857)
1. Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.
Mazzeo MF; De Giulio B; Senger S; Rossi M; Malorni A; Siciliano RA
Protein Sci; 2003 Nov; 12(11):2434-42. PubMed ID: 14573857
[TBL] [Abstract][Full Text] [Related]
2. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
3. Biochemical modifications of gliadins induced by microbial transglutaminase on wheat flour.
Mazzeo MF; Bonavita R; Maurano F; Bergamo P; Siciliano RA; Rossi M
Biochim Biophys Acta; 2013 Nov; 1830(11):5166-74. PubMed ID: 23891939
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay.
Mamone G; Ferranti P; Melck D; Tafuro F; Longobardo L; Chianese L; Addeo F
FEBS Lett; 2004 Mar; 562(1-3):177-82. PubMed ID: 15044021
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
6. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
[TBL] [Abstract][Full Text] [Related]
7. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.
Piper JL; Gray GM; Khosla C
Biochemistry; 2002 Jan; 41(1):386-93. PubMed ID: 11772038
[TBL] [Abstract][Full Text] [Related]
8. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.
Fleckenstein B; Qiao SW; Larsen MR; Jung G; Roepstorff P; Sollid LM
J Biol Chem; 2004 Apr; 279(17):17607-16. PubMed ID: 14747475
[TBL] [Abstract][Full Text] [Related]
11. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
[TBL] [Abstract][Full Text] [Related]
12. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
13. Transamidation Down-Regulates Intestinal Immunity of Recombinant α-Gliadin in HLA-DQ8 Transgenic Mice.
Rossi S; Giordano D; Mazzeo MF; Maurano F; Luongo D; Facchiano A; Siciliano RA; Rossi M
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209932
[TBL] [Abstract][Full Text] [Related]
14. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
[TBL] [Abstract][Full Text] [Related]
15. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
Arentz-Hansen H; McAdam SN; Molberg Ø; Fleckenstein B; Lundin KE; Jørgensen TJ; Jung G; Roepstorff P; Sollid LM
Gastroenterology; 2002 Sep; 123(3):803-9. PubMed ID: 12198706
[TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development.
Novák P; Man P; Tucková L; Tlaskalová-Hogenová H; Bezouska K; Havlícek V
J Mass Spectrom; 2002 May; 37(5):507-11. PubMed ID: 12112756
[TBL] [Abstract][Full Text] [Related]
18. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
19. Increased HLA-DQ2-affinity of a synthetic gliadin peptide by acid-induced deamidation of glutamine residues.
Terreaux C; Walk T; van de Wal Y; Koning F; Jung G; Fleckenstein B
Bioorg Med Chem Lett; 1998 Aug; 8(15):2039-44. PubMed ID: 9873482
[TBL] [Abstract][Full Text] [Related]
20. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.
Sjöström H; Lundin KE; Molberg O; Körner R; McAdam SN; Anthonsen D; Quarsten H; Norén O; Roepstorff P; Thorsby E; Sollid LM
Scand J Immunol; 1998 Aug; 48(2):111-5. PubMed ID: 9716100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]